524711 VISTAPH

Vista Pharmaceuticals Share Price

₹12.10 -0.15 (-1.22%)

18 Nov, 2024 20:01

SIP TrendupStart SIP in VISTAPH

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month -3.2%
  • Over 3 Month -11.23%
  • Over 6 Month -12.38%
  • Over 1 Year -34.95%
SIP Lightning

Smart Investing Starts Here Start SIP with Vista Pharmaceuticals for Steady Growth!

Invest Now

Vista Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Vista Pharmaceuticals Financials

Vista Pharmaceuticals Technicals

EMA & SMA

Current Price
₹12.10
-0.15 (-1.22%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹12.47
  • 50 Day
  • ₹12.76
  • 100 Day
  • ₹13.10
  • 200 Day
  • ₹13.39

Resistance and Support

12.1 Pivot Speed
  • R3 13.46
  • R2 13.01
  • R1 12.55
  • S1 11.64
  • S2 11.19
  • S3 10.73

What's your outlook on Vista Pharmaceuticals?

You can only vote for once

Vista Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-13 Quarterly Results
2024-05-28 Audited Results
2024-02-10 Quarterly Results
2023-11-10 Quarterly Results

Vista Pharmaceuticals F&O

Vista Pharmaceuticals Shareholding Pattern

No data available.

About Vista Pharmaceuticals

  • NSE Symbol
  • VISTAPH
  • BSE Symbol
  • 524711
  • ISIN
  • INE427C01021

Similar Stocks to Vista Pharmaceuticals

Vista Pharmaceuticals FAQs

Vista Pharmaceuticals share price is ₹12 As on 18 November, 2024 | 19:47

The Market Cap of Vista Pharmaceuticals is ₹55.2 Cr As on 18 November, 2024 | 19:47

The P/E ratio of Vista Pharmaceuticals is -16.4 As on 18 November, 2024 | 19:47

The PB ratio of Vista Pharmaceuticals is 1.4 As on 18 November, 2024 | 19:47

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23